A

Acıbadem Kozyatagı Hospital | Gastroenterology Department

Research site
(Unclaimed)
Location
19 Mayis Mahallesi Kozyatagı Kavsagı No:24 Floor 2, Istanbul, Istanbul, Turkey
Site insights

Top conditions

Colitis (3 trials)

Ulcer (3 trials)

Ulcerative Colitis (3 trials)

Crohn Disease (1 trial)

Skin Diseases (1 trial)

Top treatments

ABX464
Guselkumab
Mirikizumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 5
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Enrolling
Crohn's Disease
Drug: Mirikizumab

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis...

Active, not recruiting
Ulcerative Colitis
Drug: Guselkumab
Drug: Placebo

This is a multicenter, randomized study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as mainten...

Enrolling
Ulcerative Colitis
Drug: Placebo
Drug: ABX464

This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinica...

Enrolling
Ulcerative Colitis
Drug: ABX464
Drug: Placebo

Trial sponsors

A

ABIVAX (2 trials)

Janssen logo

Janssen (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems